Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NICardipine for Fast Achievement of Systolic BP Targets in ICH - a Quasi-randomized, Implementation Trial With Stepwise Rollout of Nicardipin Based Treatment of Hypertension.

NCT07044232 is registered in ClinicalTrials.gov with Aarhus University Hospital as lead sponsor.

NCT NCT07044232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07044232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NICardipine for Fast Achievement of Systolic BP Targets in ICH - a Quasi-randomized, Implementation Trial With Stepwise Rollout of Nicardipin Based Treatment of Hypertension.
Lead sponsor
Aarhus University Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
October 1, 2025
Completion date
September 30, 2027
Enrollment
88 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intracerebral haemorrhage